Found: 15
Select item for more details and to access through your institution.
Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 1237, doi. 10.3390/curroncol29020105
- By:
- Publication type:
- Article
Cost of home palliative care compared with conventional hospital care for patients with haematological cancers in Greece.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1907, doi. 10.3390/cancers12071907
- By:
- Publication type:
- Article
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 3, p. 591, doi. 10.1007/s10549-014-3202-5
- By:
- Publication type:
- Article
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 95, doi. 10.1007/s10549-009-0468-0
- By:
- Publication type:
- Article
Malignant myoepithelioma of the breast: A case report and review of the literature.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 351, doi. 10.1007/s00280-011-1694-9
- By:
- Publication type:
- Article
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 63, doi. 10.1007/s00280-010-1427-5
- By:
- Publication type:
- Article
Hematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid Cancer.
- Published in:
- Thyroid, 2010, v. 20, n. 6, p. 597
- By:
- Publication type:
- Article
A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract.
- Published in:
- Oncology, 2010, v. 78, n. 5/6, p. 356, doi. 10.1159/000320462
- By:
- Publication type:
- Article
Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group.
- Published in:
- Oncology, 2010, v. 78, n. 3/4, p. 229, doi. 10.1159/000315729
- By:
- Publication type:
- Article
Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma.
- Published in:
- Oncology, 2006, v. 70, n. 4, p. 280, doi. 10.1159/000096249
- By:
- Publication type:
- Article
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
- Published in:
- Oncology Letters, 2022, v. 23, n. 4, p. N.PAG, doi. 10.3892/ol.2022.13235
- By:
- Publication type:
- Article